NCT05974124 is a NA clinical trial of Povidone-Iodine 0.66% in Antiseptics, sponsored by Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia.

Who is sponsoring NCT05974124?

NCT05974124 is sponsored by Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia.

What drugs are being tested in NCT05974124?

Interventions in NCT05974124: Povidone-Iodine 0.66%, Chlorhexidine 0.02%.

What condition does NCT05974124 study?

NCT05974124 studies Antiseptics, Microbiota, Conjunctiva.

Is NCT05974124 still recruiting?

NCT05974124 is currently completed. Last updated 4 August 2023.

Last reviewed 2023-08-04 · How we verify

NCT05974124

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effectiveness of Ophthalmic Antiseptic Preparations

Completed NA Last updated 4 August 2023

What this trial tests

NA trial testing Povidone-Iodine 0.66% in Antiseptics in 70 participants. Completed in 3 February 2023.

Timeline

9 November 2022

Primary endpoint
3 February 2023

3 February 2023

Quick facts

Lead sponsor	Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	70
Start date	9 November 2022
Primary completion	3 February 2023
Estimated completion	3 February 2023
Sites	1 location across Italy

Drugs / interventions tested

Povidone-Iodine 0.66%
Chlorhexidine 0.02%

Conditions studied

Antiseptics — all drugs for Antiseptics →
Microbiota — all drugs for Microbiota →
Conjunctiva — all drugs for Conjunctiva →

Sponsor

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia — full company profile →

Who can join

18 and older, any sex, with Antiseptics or Microbiota. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this clinical trial is to evaluate the effectiveness of two topical antiseptics, povidone-iodine (PVI) and chlorhexidine (CHX), in reducing conjunctival bacterial flora.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia trials

Trials by the same sponsor.

NCT06493708 — Effectiveness of EMDR in Borderline Personality Disorder · NA · recruiting
NCT07370961 — Pilot Study to Evaluate the Impact of a Multidisciplinary Approach (Pharmacological and Psychological) in the Treatment · NA · completed
NCT05847387 — The Viability Control of Human Endothelial Cells Before Keratoplasty (V-CHECK) Study · recruiting
NCT05738902 — Adherence and Compliance to ERAS in Gynecological Surgery · unknown
NCT06765343 — Efficacy of Guided Biofilm Therapy in Pediatric Patient · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05974124 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Last refreshed: 4 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05974124.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing